Medley, Inc (MDLYF) Fair Value & Analysis
Healthcare · US · Market cap $406M
Medley, Inc
MDLYF · US
Fair value as of: Jul 19, 2026
From 24 valuation models · updated 22 days ago
Fair value updated Jul 19, 2026, revised from $5.00 to $4.02 (−19.6%) since Jun 24, 2026.
A solid business, but screening 70% overvalued on our models.
What matters now
- The price sits above even our optimistic bull case ($5.03). The favourable scenario is already priced in.
- Solid but not exceptional quality (65/100) and above fair value, neither a clear bargain nor a standout compounder.
Price vs Fair Value (2 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 19, 2026.
How to read this chart
24‑month range $13.52 – $24.00 · fair‑value band $3.02 – $5.03 · the $13.52 price screens above the $4.02 fair value. Dashed = 300-day average. As of Jul 19, 2026.
Analysis
Medley, Inc (MDLYF) currently trades at $13.52, while our model-based Fair Value estimate is $4.02, implying the stock looks roughly 70.3% overvalued today. The Quality Score stands at 65/100 (solid quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).
Over the trailing twelve months, Medley, Inc generated revenue of $38.8B at a net margin of 2.5%. Revenue grew 25.2% year over year. It earns a return on equity of 6.3%. Net debt stands at $7.5B. Fundamentals as of Jul 19, 2026
Our scenario range runs from $3.02 (bear case) to $5.03 (bull case); at $13.52, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 41% below its 52-week high, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -53% fair-value upside, at -70%, MDLYF screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 24 models by family
Widest divergence: DCF Models ($11.49) versus Asset-Based ($2.04). Highest evidence: Growth DCF (80).
Notify me when MDLYF reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 19, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 65 · Market factors (momentum, volatility) 19
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Medley, Inc. operates platforms for recruitment and medical businesses in Japan and the United States. It operates through three segments: Human Resources Platform Business, Medical Platform Business, and New Development Services.
Full company description
Medley, Inc. operates platforms for recruitment and medical businesses in Japan and the United States. It operates through three segments: Human Resources Platform Business, Medical Platform Business, and New Development Services. The company manages JobMedley, a human resource recruitment system for medical and healthcare, and related businesses; JobMedley Academy, an online video nursing training service; Medley, an electronic medical records for hospitals; Mall, a cloud dental business support system; Dentis, a cloud based dental clinic supports system; CLINICS Telemedicine, a telemedicine system for patients and medical institutions; CLINICS, a cloud medical support system; Pharms, pharmacy window support systems; Lalune, a women health consultation application; and Jobley for job board. It also operates and provides the facility reservation system @link. The company was incorporated in 2009 and is headquartered in Minato, Japan.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Medley, Inc reported revenue of $36.8B in FY2025 versus $10.9B in FY2021, a compound +35.7%/yr. Reported net income was $975M in FY2025, compounding +14.7%/yr from FY2021.
MDLYF screens 70% overvalued. Compare with Veeva Systems Inc →
Peer Group
Health Information Services · 126 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Health Information Services median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Health Information Services stocks, each showing price versus our Fair Value estimate (as of Jul 19, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Veeva Systems Inc VEEV | $190.12 | $95.12 | -50% |
| Pro Medicus Limited PME | A$194.84 | A$23.74 | -88% |
| BrightSpring Health Services, Inc BTSG | $68.16 | $21.31 | -69% |
| HealthEquity, Inc HQY | $97.67 | $56.63 | -42% |
| Hinge Health, Inc HNGE | $88.80 | $24.03 | -73% |
| 10x Genomics, Inc TXG | $45.75 | $17.18 | -62% |
| Waystar Holding WAY | $22.69 | $12.86 | -43% |
| Doximity, Inc DOCS | $22.21 | $17.18 | -23% |
| Privia Health Group PRVA | $28.10 | $5.30 | -81% |
| Inventurus Knowledge Solutions Limited IKS | ₹1,846 | ₹860.28 | -53% |
Compare Medley, Inc with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Medley, Inc (MDLYF) overvalued or undervalued?
What is the fair value of MDLYF?
What is the quality score of MDLYF?
What is the revenue of Medley, Inc (MDLYF)?
What is the net profit margin of MDLYF?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Medley, Inc and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.